 ZUG, Switzerland and BOSTON, Sept. 29, 2022 GLOBE NEWSWIRE -- CRISPR Therapeutics Nasdaq: CRSP, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in 